The Blog to Learn More About Fibrillar Absorbable Hemostat and its Importance

The Blog to Learn More About Fibrillar Absorbable Hemostat and its Importance

Blog Article


Fibrillar Absorbable Hemostat: A Promising Aid for Bleeding Control in Colorectal Tumors

Colorectal cancer, among the most prevalent cancers worldwide, frequently requires sophisticated treatment modalities to achieve optimum results. Among these, endoscopic submucosal dissection (ESD) has become an appealing method for the early-stage management of colorectal tumors. However, the procedure's success can be tempered by postoperative issues such as postponed bleeding and perforation, in addition to the challenge of handling large mucosal defects. Moreover, direct exposure to gastrointestinal flora increases the risk of bacteremia and endotoxemia. In the mission for safer and more reliable services, researchers and clinicians are continuously exploring alternative approaches. Fibrillar absorbable hemostat such as Surgicel ® Fibrillar ™ (Ethicon), nevertheless, emerges as a game-changer uses a multifaceted approach to post-ESD care, supplying both hemostatic support and localized bactericidal results.

A noteworthy item in this realm is Surgi-ORC ® Fibril from Aegis Lifesciences, including the following key qualities:

Key Features of Surgi-ORC ® Fibril:

• Lightweight, tufted, soft and layered structure
• Provides high versatility and conformability to surgical sites
• Suitable for irregular shaped wounds and hard-to-reach areas
• Bactericidal properties
• Soft, layered product conforms and "melts in" to bleeding tissue
• Completely absorbable
• 7 layers fibrillose fabric
• Designed for hemostasis in

How does Surgi-ORC ® Fibril Work?
Surgi-ORC ® Fibrilis made up of oxidized regenerated cellulose, which, upon contact with blood, swells into a Fibrillar Absorbable Hemostat gelatinous mass, aiding in clot development and preventing additional bleeding. Additionally, its low pH of 3.4 exhibits powerful bactericidal properties, reducing the risk of infection considerably.

Clinical Study Results:

A clinical study was performed at the University of Soonchunhyang Hospital in Bucheon, Korea, sheds light on the efficiency of Surgicel ® Fibrillar ™ in colorectal ESD. In a cohort of 49 patients, Surgicel ® Fibrillar ™ was effectively applied to cover the whole mucosal defect following ESD, without any Surgicel-related problems. Extremely, none of the clients in the Surgicel group experienced delayed bleeding or perforation, marking a considerable enhancement over standard ESD techniques. Moreover, Surgicel ® Fibrillar ™ was connected with much shorter medical facility stays and lower inflammatory markers, suggesting quicker healing and enhanced postoperative results.

Fig. 1: A) Lateral spreading tumor; B) Dissected colon LST by colon endoscopic submucosal dissection.; C) Surgicel was positioned onto the mucosal defect to cover the whole mucosal defect; D) Surgicel swelled into a gelatinous mass [1]


In the realm of colorectal cancer treatment, every development brings us closer to our supreme objective: enhancing client results and enhancing quality of life. Fibrillar absorbable hemostat represents a pivotal milestone in this journey, providing a potent combination of hemostatic efficacy and antimicrobial security. As we continue to push the limits of innovation, let us accept the transformative potential of Fibrillar absorbable hemostat and embark on a path towards safer, more effective colorectal endoscopic resection.


[1] Myung YS, Ko BM, Han JP, Hong SJ, Jeon SR, Kim JO, Moon JH, Lee MS. Effectiveness of Surgicel® (Fibrillar) in patients with colorectal endoscopic submucosal dissection. Surgical endoscopy. 2016 Apr;30:1534-41. DOI:10.1007/s00464-015-4369-5

Article Tags: Fibrillar Absorbable Hemostat, Fibrillar Absorbable Topical Hemostat.

Report this page